| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 11,589 | $775,197 | $66.89 | 17 Nov 2025 | Direct |
| BridgeBio Pharma, Inc. | Director | Common Stock | 4,000 | $266,480 | $66.62 | 17 Nov 2025 | By Thinking Bench Capital LLC |
| Invitae Corp | Director | Common Stock | 161,222 | $104,472 | $0.6480 | 27 Apr 2023 | Direct |
| Invitae Corp | Director | Common Stock | 60,000 | $38,880 | $0.6480 | 27 Apr 2023 | By OG Family Trust |
| Talis Biomedical Corp | Director | Stock option (right to buy) | 95,000 | 09 Jun 2023 | Direct | ||
| Invitae Corp | Director | Stock Option (right to buy) | 86,705 | 27 Apr 2023 | Direct | ||
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 41,501 | 17 Nov 2025 | Direct |